The 2nd HARMONY General Assembly is organised from 23-24 October 2017 at Bayer in Berlin. Bayer is one of the 52 HARMONY Alliance Partners.
At the General Assembly Alliance Partners and Associated Members meet to discuss topics that are important for all stakeholders and patients to get access to the right treatment at the right time, such as definition and alignment on outcomes.
Apart from presentations, parallel sessions are organised across the spectrum of hematologic malignancies: multiple myeloma (MM), acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), chronic lymphocytic leukemia (CLL), non-Hodgkins lymphoma (NHL), myelodysplastic syndromes (MDS), and pediatric Hematologic Malignancies.
The General Assembly is a valuable bi-annual meeting to attend for Alliance Partners and Associated Members, both from a substance as from a collaborative perspective.
During our two day event we will set up our studio and would like to invite you to talk about Big Data and Hematolog! Share the HARMONY vision and/or share your experiences in the field on video; add your personal view on the challenges we face when addressing the unmet needs with HM patients. May we interview you as well? Let's talk and mail us to set the timeframe.
Are you interested in starting your research project while using big data analyses from HARMONY? Join our Alliance and become an Associate Member. Please contact the Coordination Office at email@example.com.